Vitamin D Improves Depression in Liver Patients
CLDVitD
Clinical Trial Investigating the Role of Vitamin D in the Treatment of Depression in Patients With Chronic Liver Disease
1 other identifier
interventional
111
1 country
1
Brief Summary
This study evaluates the efficacy of vitamin D replacement therapy in reducing depressive symptoms in patients with chronic liver disease and vitamin D deficiency. Patients with normal vitamin D levels will be monitored as controls, and they will not receive any intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 4, 2015
CompletedFirst Posted
Study publicly available on registry
February 9, 2015
CompletedFebruary 9, 2015
February 1, 2015
2 years
February 4, 2015
February 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes to depressive symptoms as assessed using the BDI-II score
3 and 6 months
Secondary Outcomes (2)
Changes to serum liver function tests, as assessed using standard clinical-chemical assays
3 and 6 months
Changes to bone density, as assessed using Dexa scans
at 12 months
Study Arms (2)
Vitamin D supplement
EXPERIMENTAL20,000 IU cholecalciferol p.o for the first 7 days, and weekly thereafter for 6 months
Controls
NO INTERVENTIONThese patients had normal vitamin D levels and did not receive any treatment with vitamin D.
Interventions
Given to patients with existing vitamin D deficiency
Eligibility Criteria
You may qualify if:
- men and women
- over 18 years of age
- chronic liver disease
You may not qualify if:
- severe hepatic encephalopathy (CFF \<35 Hz)
- Interferon treatment
- hypercalcaemia (\>2.7 mmol/l) or hypercalciuria (\>8.0 mmol/d) with or without hyperparathyroidism (\>65.0 pg/ml)
- history of calcium-containing kidney stones
- allergy or hypersensitivity to any of the supplement ingredients: peanuts, soy, gelatin
- sarcoidosis
- stage IV or V Chronic Kidney Disease
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saarland University Medical Center
Homburg, Saarland, 66421, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Frank Lammert, MD
Saarland University Medical Center
- PRINCIPAL INVESTIGATOR
Caroline S Stokes, PhD
Saarland University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
February 4, 2015
First Posted
February 9, 2015
Study Start
December 1, 2011
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
February 9, 2015
Record last verified: 2015-02